NCT03388541View on ClinicalTrials.gov

Low Dose Dexmedetomidine and Delirium After Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

August 12, 2019

Study Completion Date

August 12, 2019

Conditions
Cardiac Surgical Procedures
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine will be started at 5mL/h while the patient is still in the operating room. The patient will be transferred to the intensive care unit with a sedative regimen based on propofol.

DRUG

Placebo

A continuous infusion of NaCL 0.9% will be started at 5mL/h while the patient is still in the operating room. The patient will be transferred to the intensive care unit with a sedative regimen based on propofol.

Trial Locations (1)

1200

Cliniques Universitaires Saint Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT03388541 - Low Dose Dexmedetomidine and Delirium After Cardiac Surgery | Biotech Hunter | Biotech Hunter